JSP191
JSP-CP-008
Phase 1 small_molecule terminated
Quick answer
JSP191 for Lower-risk Myelodysplastic Syndrome is a Phase 1 program (small_molecule) at Jasper Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jasper Therapeutics
- Indication
- Lower-risk Myelodysplastic Syndrome
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated